NCT02806895 Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA Status COMPLETED Phase PHASE2
NCT02769780 A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy Status COMPLETED Phase N/A
NCT02718755 Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies Status WITHDRAWN Phase PHASE2
NCT02660255 Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy Status APPROVED_FOR_MARKETING Phase N/A
NCT02647190 Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older Status WITHDRAWN Phase PHASE1
NCT02607904 An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy Status COMPLETED Phase PHASE2
NCT02607891 A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy Status COMPLETED Phase PHASE2
NCT02596997 Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease Status NO_LONGER_AVAILABLE Phase N/A
NCT02565108 A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol Status COMPLETED Phase PHASE2
NCT02564952 An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol Status COMPLETED Phase PHASE2
NCT02544763 A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) Status COMPLETED Phase PHASE3
NCT02544750 An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) Status COMPLETED Phase PHASE3
NCT02539823 Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans Status COMPLETED Phase PHASE2
NCT02533115 EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML Status APPROVED_FOR_MARKETING Phase N/A
NCT02439970 A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease Status TERMINATED Phase PHASE3
NCT02439957 A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Status TERMINATED Phase PHASE3
NCT02420080 A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304 Status TERMINATED Phase N/A
NCT02419469 Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status TERMINATED Phase PHASE2